Related Experiment Video
Updated: Jul 11, 2026
Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells
Published on: July 18, 2019
A validated method for quantifying macrovesicular hepatic steatosis in chronic hepatitis C
Tom H Boyles1, Sarah Johnson, Nigel Garrahan
1Department of Infectious Diseases, University Hospital of Wales, Cardiff, Wales, UK. tomboyles@yahoo.com
Insights
A new computer-assisted method accurately quantifies hepatic steatosis in chronic hepatitis C (HCV) patients. This fast, reliable technique offers a validated approach for research, complementing existing clinical methods.
Area of Science:
- Hepatology
- Medical Imaging
- Digital Pathology
Background:
- Hepatic steatosis is a significant prognostic factor in chronic hepatitis C (HCV) infection.
- Current semiquantitative methods for steatosis assessment lack validation in HCV cohorts.
- Existing computer-assisted methods for steatosis quantification lack validation against a gold standard.
Purpose of the Study:
- To present and validate a novel computer-assisted morphometric analysis method for quantifying hepatic steatosis.
- To establish a gold standard for manual measurement of hepatic steatosis.
- To assess the reliability and speed of the proposed computer-assisted method compared to manual measurements.
Main Methods:
- Development of a novel computer-assisted morphometric analysis technique for steatosis quantification.
- Establishment of a gold standard using manual measurements with low interobserver error (mean of 3 observations).
- Validation of the computer-assisted method against the proposed manual gold standard.
Main Results:
- The manual method demonstrated minimal interobserver error, serving as a reliable gold standard.
- The computer-assisted method accurately identified biopsies with <1% steatosis (7/7).
- The computer-assisted method accurately predicted gold standard values for biopsies >1% steatosis (geometric mean ratio 0.85, 95% CIs 0.77-0.95).
Conclusions:
- A novel computer-assisted morphometric analysis method for hepatic steatosis is fast, reliable, and validated.
- This method is suitable for future research in chronic hepatitis C steatosis and reanalysis of previous studies.
- The semiquantitative method remains appropriate for clinical assessment of hepatic steatosis.
Abstract:
Hepatic steatosis is increasingly seen as an important prognostic factor in chronic hepatitis C infection (HCV). The commonly used semiquantitative method of measuring steatosis is based on a study that excluded patients with HCV. Several potentially useful methods of quantifying steatosis using computer-assisted morphometric analysis have been proposed, but none has been validated against a proposed gold standard other than the method they were intended to replace. We present a novel method and propose a gold standard based on manual measurements. The manual method is time consuming but shows little interobserver error, and the mean value of 3 observations by separate investigators is proposed as the gold standard. The computer-assisted method is fast, with a single interactive step that shows minimal interobserver variation. It accurately identifies biopsies with <1% steatosis (7 of 7) and predicts the gold standard value for biopsies with > 1% steatosis with narrow CIs (geometric mean ratio 0.85 with 95% CIs 0.77-0.95). This novel method of computer-assisted morphometric analysis is fast, reliable, and suitable for future research in HCV steatosis. It may be used to reanalyze previous studies. The semiquantitative method of assessing steatosis remains appropriate for clinical purposes.
